Loading...
KYORIN Holdings, Inc.
4569.T•JPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥1543.00
¥20.00(1.31%)
KYORIN Holdings, Inc. (4569.T) Financial Performance & Income Statement Overview
Review KYORIN Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.83%
↑ 8.83%
Operating Income Growth
108.66%
↑ 108.66%
Net Income Growth
70.73%
↑ 70.73%
Operating Cash Flow Growth
126.34%
↑ 126.34%
Operating Margin
9.66%
↑ 9.66%
Gross Margin
45.76%
↑ 45.76%
Net Profit Margin
6.98%
↑ 6.98%
ROE
6.90%
↑ 6.90%
ROIC
7.93%
↑ 7.93%
KYORIN Holdings, Inc. (4569.T) Income Statement & Financial Overview
Review KYORIN Holdings, Inc.'s (4569.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $40.80B | $34.15B | $26.72B | $28.42B |
| Cost of Revenue | $19.94B | $19.04B | $15.51B | $16.07B |
| Gross Profit | $20.86B | $15.11B | $11.21B | $12.35B |
| Gross Profit Ratio | $0.51 | $0.44 | $0.42 | $0.43 |
| R&D Expenses | $0.00 | $4.21B | $1.77B | $2.07B |
| SG&A Expenses | $11.41B | $9.33B | $9.04B | $9.13B |
| Operating Expenses | $11.41B | $13.54B | $10.81B | $11.20B |
| Total Costs & Expenses | $31.35B | $32.58B | $26.32B | $27.27B |
| Interest Income | $1.00M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $70.00M | $0.00 | $0.00 | $18.00M |
| Depreciation & Amortization | $1.18B | $1.07B | $1.15B | $1.07B |
| EBITDA | $10.75B | $2.63B | $1.55B | $2.22B |
| EBITDA Ratio | $0.26 | $0.08 | $0.06 | $0.08 |
| Operating Income | $9.45B | $1.57B | $399.00M | $1.15B |
| Operating Income Ratio | $0.23 | $0.05 | $0.01 | $0.04 |
| Other Income/Expenses (Net) | -$247.00M | $134.00M | $165.00M | $155.00M |
| Income Before Tax | $9.20B | $1.70B | $564.00M | $1.30B |
| Income Before Tax Ratio | $0.23 | $0.05 | $0.02 | $0.05 |
| Income Tax Expense | $2.55B | $517.00M | $194.00M | $419.00M |
| Net Income | $6.65B | $1.18B | $370.00M | $885.00M |
| Net Income Ratio | $0.16 | $0.03 | $0.01 | $0.03 |
| EPS | $115.70 | $20.61 | $6.44 | $15.41 |
| Diluted EPS | $115.70 | $20.61 | $6.44 | $15.41 |
| Weighted Avg Shares Outstanding | $57.45M | $57.45M | $57.45M | $57.45M |
| Weighted Avg Shares Outstanding (Diluted) | $57.45M | $57.45M | $57.45M | $57.45M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan